Aprepitant an antiemetic, is a substance P/neurokinin 1 (NK1) receptor antagonist which, in combination with other antiemetic agents. Aprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). It was approved by the Food and Drug Administration (FDA) in 2003. In 2008, fosaprepitant, an intravenous form of Aprepitant was approved.
SynZeal offers all Aprepitant related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Aprepitant related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.